Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Performance of Biotech IPOs Relative to Cash on Hand

This article was originally published in Start Up

Executive Summary

While the majority of the biotech IPO class of 2000 have plummeted from their highs, some continue to do comparatively well. To add an extra dimension to tracking the performance of these biotechs since their IPOs, we've plotted the ten companies with the most cash on hand post-IPO against a group with the least to see if those companies with stronger cash positions were better able than their peers to survive the current bear market.
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC090464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel